Market Closed -
Nasdaq
04:00:00 2024-05-28 pm EDT
|
5-day change
|
1st Jan Change
|
7.65
USD
|
+3.80%
|
|
-0.39%
|
-36.30%
|
Fiscal Period: February |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Capitalization
1 |
2,452
|
1,204
|
808.7
|
793.4
|
577.5
|
-
|
-
|
Enterprise Value (EV)
1 |
2,018
|
1,119
|
769.9
|
793.4
|
408.9
|
400.9
|
390.3
|
P/E ratio
|
-25.8
x
|
-9.32
x
|
-1.72
x
|
-7.71
x
|
-6.16
x
|
-6.94
x
|
-10
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
14.4
x
|
3.88
x
|
2.23
x
|
1.92
x
|
1.18
x
|
1.01
x
|
0.84
x
|
EV / Revenue
|
11.8
x
|
3.61
x
|
2.12
x
|
1.92
x
|
0.83
x
|
0.7
x
|
0.57
x
|
EV / EBITDA
|
-74.9
x
|
-26.4
x
|
-21.1
x
|
-106
x
|
24.6
x
|
11.2
x
|
5.62
x
|
EV / FCF
|
-74.1
x
|
-17.2
x
|
-18
x
|
-37.6
x
|
16.8
x
|
10.7
x
|
7.84
x
|
FCF Yield
|
-1.35%
|
-5.8%
|
-5.56%
|
-2.66%
|
5.94%
|
9.32%
|
12.8%
|
Price to Book
|
6.32
x
|
1.41
x
|
1.67
x
|
-
|
1.41
x
|
1.42
x
|
1.34
x
|
Nbr of stocks (in thousands)
|
55,321
|
66,958
|
72,787
|
77,408
|
78,357
|
-
|
-
|
Reference price
2 |
44.32
|
17.98
|
11.11
|
10.25
|
7.650
|
7.650
|
7.650
|
Announcement Date
|
5/5/21
|
4/28/22
|
4/27/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: February |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net sales
1 |
132.5
|
170.4
|
310
|
363.1
|
414.3
|
490.1
|
574.3
|
687.2
|
EBITDA
1 |
-
|
-26.94
|
-42.38
|
-36.5
|
-7.491
|
16.59
|
35.83
|
69.5
|
EBIT
1 |
-
|
-46.78
|
-125.7
|
-463.5
|
-114.5
|
-94.43
|
-82.86
|
-62.05
|
Operating Margin
|
-
|
-27.46%
|
-40.55%
|
-127.64%
|
-27.63%
|
-19.27%
|
-14.43%
|
-9.03%
|
Earnings before Tax (EBT)
1 |
-
|
-50.65
|
-128.8
|
-463.3
|
-98.57
|
-89.26
|
-79.34
|
-58.63
|
Net income
1 |
-
|
-50.65
|
-123.1
|
-459.6
|
-99.8
|
-91.81
|
-79.73
|
-61.59
|
Net margin
|
-
|
-29.73%
|
-39.71%
|
-126.58%
|
-24.09%
|
-18.73%
|
-13.88%
|
-8.96%
|
EPS
2 |
-9.130
|
-1.720
|
-1.930
|
-6.450
|
-1.330
|
-1.243
|
-1.102
|
-0.7633
|
Free Cash Flow
1 |
-
|
-27.22
|
-64.87
|
-42.81
|
-21.1
|
24.3
|
37.37
|
49.8
|
FCF margin
|
-
|
-15.98%
|
-20.92%
|
-11.79%
|
-5.09%
|
4.96%
|
6.51%
|
7.25%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
146.43%
|
104.3%
|
71.65%
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
6/16/20
|
5/5/21
|
4/28/22
|
4/27/23
|
4/25/24
|
-
|
-
|
-
|
Fiscal Period: February |
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
2026 Q1
|
---|
Net sales
1 |
83.45
|
93.76
|
85.53
|
87.64
|
90.95
|
99.02
|
93.23
|
96.86
|
99.37
|
124.8
|
105.2
|
113.2
|
116.7
|
155
|
123.7
|
EBITDA
1 |
-11.94
|
1.818
|
-15.37
|
-13.75
|
-10.22
|
2.832
|
-12.58
|
-8.764
|
-4.626
|
18.48
|
-10.07
|
-6.231
|
1.373
|
31.69
|
-5.874
|
EBIT
1 |
-41.88
|
-29.81
|
-346
|
-45.91
|
-40.38
|
-31.19
|
-39.63
|
-35.21
|
-31.72
|
-7.897
|
-37
|
-34.26
|
-26.19
|
2.446
|
-35.9
|
Operating Margin
|
-50.19%
|
-31.8%
|
-404.59%
|
-52.38%
|
-44.4%
|
-31.49%
|
-42.51%
|
-36.35%
|
-31.92%
|
-6.33%
|
-35.17%
|
-30.26%
|
-22.44%
|
1.58%
|
-29.03%
|
Earnings before Tax (EBT)
1 |
25.83
|
-30.69
|
-346.7
|
-46.27
|
-39.8
|
-30.48
|
-38.32
|
-32.74
|
-20.73
|
-6.778
|
-35.47
|
-32.6
|
-24.5
|
2.726
|
-35.4
|
Net income
1 |
22.5
|
-34.56
|
-342.8
|
-46.52
|
-39.87
|
-30.43
|
-38.41
|
-32.82
|
-21.06
|
-7.507
|
-36.38
|
-33.5
|
-25.2
|
2.466
|
-36.1
|
Net margin
|
26.97%
|
-36.86%
|
-400.83%
|
-53.08%
|
-43.84%
|
-30.73%
|
-41.2%
|
-33.89%
|
-21.2%
|
-6.01%
|
-34.58%
|
-29.59%
|
-21.59%
|
1.59%
|
-29.19%
|
EPS
2 |
0.3100
|
-0.5100
|
-4.920
|
-0.6600
|
-0.5600
|
-0.4200
|
-0.5200
|
-0.4300
|
-0.2800
|
-0.1000
|
-0.4803
|
-0.4378
|
-0.3403
|
0.0255
|
-0.4457
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/10/22
|
4/28/22
|
6/30/22
|
10/6/22
|
1/9/23
|
4/27/23
|
6/29/23
|
10/4/23
|
1/8/24
|
4/25/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: February |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
2027
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
434
|
85.2
|
38.8
|
-
|
169
|
177
|
187
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-27.2
|
-64.9
|
-42.8
|
-21.1
|
24.3
|
37.4
|
49.8
|
ROE (net income / shareholders' equity)
|
-
|
-72.5%
|
-19.8%
|
-69.1%
|
-
|
-20.3%
|
-18%
|
-14%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
-
|
7.020
|
12.80
|
6.650
|
-
|
5.440
|
5.390
|
5.690
|
Cash Flow per Share
2 |
-
|
-0.8600
|
-0.9800
|
-0.5700
|
-0.2200
|
0.4400
|
0.6400
|
-
|
Capex
1 |
-
|
1.99
|
2.52
|
2.11
|
4.94
|
5.43
|
6.13
|
3.5
|
Capex / Sales
|
-
|
1.17%
|
0.81%
|
0.58%
|
1.19%
|
1.11%
|
1.07%
|
0.51%
|
Announcement Date
|
6/16/20
|
5/5/21
|
4/28/22
|
4/27/23
|
4/25/24
|
-
|
-
|
-
|
Last Close Price
7.65
USD Average target price
13.07
USD Spread / Average Target +70.81% Consensus |
1st Jan change
|
Capi.
|
---|
| -36.30% | 577M | | +17.73% | 83.47B | | -32.08% | 69.72B | | -3.24% | 26.37B | | +4.13% | 17.86B | | -13.68% | 16.83B | | +0.75% | 15.7B | | +74.92% | 13.45B | | +73.16% | 12.81B | | -2.02% | 12.44B |
Other Healthcare Facilities & Services
|